Latest news
Can New VASCADE MVP XL Data Strengthen Haemonetics' (HAE) Moat in Electrophysiology Adjacent Markets? - simplywall.stsimplywall.st · Tue, 04 Aug 2026 20:49:05 GMTHaemonetics (HAE) Is Up 5.1% After New VASCADE MVP XL Real-World Study Data Release – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 20:10:01 GMT